Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cost evaluation of multiple sclerosis.

M A Battaglia1, P Zagami, M M Uccelli

  • 1Institute of Hygiene, University of Siena, Italy.

Journal of Neurovirology
|June 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indirect Costs Related to Productivity Loss, Work-Related Quality of Life, and Resource Utilization in Workers with Multiple Sclerosis.

Journal of occupational rehabilitation·2026
Same author

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026
Same author

Real-world safety and efficacy profiles of trastuzumab deruxtecan in patients with advanced breast cancer.

ESMO open·2025
Same author

Can selective estrogen receptor-α covalent antagonist (SERCA) be a new treatment for breast cancer?

ESMO open·2025
Same author

Molecular tumour board in gastrointestinal cancers.

ESMO open·2025
Same author

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Multiple sclerosis (MS) is a costly chronic disease, with indirect costs like lost income significantly outweighing direct medical expenses. Understanding the full economic burden, including intangible factors, is crucial for managing MS impact.

Area of Science:

  • Neurology
  • Health Economics
  • Public Health

Background:

  • Multiple sclerosis (MS) is a chronic, disabling neurological condition with substantial societal and individual economic consequences.
  • Existing research highlights the significant financial burden of MS, impacting patients, families, and healthcare systems.
  • The long duration and early onset of MS contribute to its extensive and escalating costs.

Purpose of the Study:

  • To comprehensively analyze the direct and indirect economic costs associated with multiple sclerosis.
  • To investigate the impact of MS on employment and income for patients and caregivers.
  • To explore the 'intangible' costs of MS, including effects on quality of life, and to evaluate the cost-benefit of new therapies like beta interferon.

Main Methods:

Related Experiment Videos

  • Review of existing studies on the economic burden of multiple sclerosis in developed countries.
  • Analysis of cost components, including direct medical expenses (treatment, hospitalization, assistance) and indirect costs (lost income).
  • Consideration of informal care burdens and intangible costs impacting quality of life.

    • Main Results:

    • Indirect costs, primarily lost income due to reduced work activity, constitute up to 75% of the total economic burden of MS.
    • Direct costs, such as medical visits and treatment, are considerably lower than indirect costs.
    • Informal care places a significant burden on families, and the intangible costs of MS remain largely unquantified.

    Conclusions:

    • The economic impact of multiple sclerosis is predominantly driven by indirect costs related to employment and productivity loss.
    • Further research is needed to quantify intangible costs and determine the cost-effectiveness of novel MS therapies.
    • A holistic approach is required to address the multifaceted economic challenges posed by multiple sclerosis.